Brief: Arecor And Trx Biosciences Establish Research Collaboration To Develop Oral Glp-1 With Enhanced Bioavailability
12/03/2024 11:50
March 12 (Reuters) - Arecor Therapeutics PLC AREC.L :
* ARECOR AND TRX BIOSCIENCES ESTABLISH RESEARCH
COLLABORATION TO
DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITY
* ARECOR THERAPEUTICS PLC: COMPANIES TO COMBINE PROPRIETARY
TECHNOLOGIES TO FORMULATE AN ORAL SEMAGLUTIDE (GLP-1 RECEPTOR
AGONIST) PRODUCT
Source text for Eikon: ID:nGNX9Ldq5w
Further company coverage: AREC.L
((Reuters.Briefs@thomsonreuters.com;))